DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

8.61 -0.06 (-0.69%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $8.61 -0.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.68
Previous Close $8.67
Daily Range $8.33 - $8.68
52-Week Range $5.60 - $12.46
Market Cap $892.1M
P/E Ratio -7.29
Dividend (Yield) $0.00 (0.0%)
Volume 438,966
Average Daily Volume 494,792
Current FY EPS -$1.30

Sector

Healthcare

Industry

Drug Makers

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexpharma.com/

News & Commentary Rss Feed

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Mid-Afternoon Market Update: Dow Dips Over 100 Points; Crude Oil Tumbles 5.5%

Mid-Afternoon Market Update: Dow Dips Over 100 Points; Crude Oil Tumbles 5.5%

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Lexicon Pharmaceuticals (LXRX) Shares March Higher, Can It Continue? - Tale of the Tape

Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?

Today's Weak On High Volume Stock: Lexicon Pharmaceuticals (LXRX)

Lexicon Undervalued As It Approaches A Major Event

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earnings Call Transcript

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syn

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

Health Care Sector Update for 04/15/2015: LXRX,BMY,CLSN,AKBA

See More LXRX News...

LXRX's Top Competitors

LXRX $8.61 (-0.69%)
Current stock: LXRX
AMGN $155.39 (0.58%)
Current stock: AMGN
CELG $119.28 (0.39%)
Current stock: CELG
GILD $115.13 (-0.46%)
Current stock: GILD